Skip to NavigationSkip to content

News

MPs have accused the UK largest public funder of medical research of poor decision-making and financial mismanagement.
GlaxoSmithKline and Bayer's erectile dysfunction is to become Viagra's first major competitor in the US after receiving marketing approval.
Schering-Plough's new chief executive and chairman Fred Hassan, has forgone a bonus of up to $2 million bonus to demonstrate his commitment to cost-...
Pharmaceutical companies should be allowed to set their own prices in all the European Union countries in order to bring a single market one step...
Final breakthrough on England's consultant contract
Pfizer could be facing a backlash from PCTs angered by the recent price rise on two of its leading products, Istin and Celebrex.
UK biotech company Cambridge Antibody Technology says it remains on target to reach profitability by 2008 despite a doubling of its operating losses...
Xenova has halted phase III clinical trials of its lead product after an independent safety committee confirmed safety fears about the drug.
The crisis surrounding the proposed new GP contract has deepened after doctors refused to be tampededinto accepting a new contract, which many say...
Fred Hassan has announced a major re-organisation of Schering-Plough pharmaceutical operations just 17 days after taking on the job of turning around...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches